Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pelota mRNA surveillance and ribosome rescue factor (PELO) is an evolutionarily conserved protein essential for cellular mRNA quality control and ribosome rescue. It functions in No-Go Decay and Non-Stop Decay pathways, collaborating with factors such as Hbs1 and ABCE1 to recognize and dissociate stalled ribosomes, thus preventing translational arrest, facilitating degradation of aberrant mRNAs, and maintaining proteostasis and fidelity of protein synthesis. In humans and other metazoans, PELO helps regulate cell proliferation, stem cell renewal, and longevity by suppressing stress from stalled translation and proteotoxicity. It also modulates oncogenic receptor tyrosine kinase signaling (e.g., HER2, EGFR), acting as a negative regulator of metastasis, and participates in the assembly of inflammasomes for innate immunity. Loss or dysregulation of PELO impairs ribosome recycling, disrupts stem cell maintenance, accelerates cellular aging, increases vulnerability to neurodegeneration, and affects transposon silencing in the germline. There are presently no drugs in clinical use that target PELO directly.
Not applicable; PELO is not a drug target. Its endogenous mechanism includes: Facilitating dissociation of stalled ribosomes and associated defective mRNAs; Maintaining translational fidelity and protein homeostasis; Attenuating oncogenic signaling via interaction with receptor tyrosine kinases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pelota mRNA surveillance and ribosome rescue factor (PELO).